deucravacitinib,apremilast
bms,amgen
['psoriasis', 'deucrava', 'deucra']
u.s. food and drug administration approves sotyktu (deucravacitinib), oral treatment for adults with moderate-to-severe plaque psoriasis - 
MD MSC CPDS https://t.co/kePCRsvthW  https://t.co/t7oxnCDRg8  #cardiology  #AI #informatics #healthcare #innovation #entrepreneur RSS feeds